TP53 and osteosarcoma: Since TP53 is a major tumor suppressor gene, its inactivation likely increases the probability of cells to circumvent apoptosis and survive chromoanagenesis which is why patients with Li–Fraumeni syndrome are known to be at higher risk to develop malignant tumors including osteosarcoma.